Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 7886956)

Published in Virology on March 10, 1995

Authors

L M Rudensey1, J T Kimata, R E Benveniste, J Overbaugh

Author Affiliations

1: Department of Microbiology, University of Washington, Seattle 98195.

Articles citing this

Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol (1997) 3.33

Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol (1999) 2.48

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J Virol (2000) 2.45

Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol (1998) 1.98

Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J Virol (1997) 1.49

In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant. J Virol (1998) 1.23

In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J Virol (2004) 1.19

Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J Virol (2001) 1.15

Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J Virol (2000) 1.14

The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env. J Virol (1997) 1.07

Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J Virol (2002) 1.04

Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5. J Virol (2003) 1.03

Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein. J Virol (1997) 0.99

A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. J Virol (1998) 0.99

Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution. J Virol (1998) 0.98

Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne. J Virol (1999) 0.95

Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J Virol (2002) 0.94

Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus. J Virol (2002) 0.91

Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T tropism: evidence for distinct levels of restriction in primary macrophages and a T-cell line. J Virol (2001) 0.91

The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV. Proc Biol Sci (1998) 0.88

Effect of synaptic transmission on viral fitness in HIV infection. PLoS One (2012) 0.84

Early- and intermediate-stage variants of simian immunodeficiency virus replicate efficiently in cells lacking CCR5. J Virol (2003) 0.83

Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling. J Virol (1998) 0.81

Changes in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4+ T cells. Virology (2007) 0.80

Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation. Retrovirology (2010) 0.79

A decrease in albumin in early SIV infection is related to viral pathogenicity. AIDS Res Hum Retroviruses (2009) 0.78

HIV-1 Transmission, Replication Fitness and Disease Progression. Virology (Auckl) (2008) 0.78

Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model. J Virol (1998) 0.77

Giant syncytia and virus-like particles in ovarian carcinoma cells isolated from ascites fluid. Clin Diagn Lab Immunol (1999) 0.77

In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4. AIDS Res Ther (2013) 0.75

Articles by these authors

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science (1995) 9.48

The origin of mutants. Nature (1988) 8.92

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (1992) 5.25

RNA in mammalian sarcoma virus transformed nonproducer cells homologous to murine leukemia virus RNA. Virology (1973) 5.04

Gender differences in HIV-1 diversity at time of infection. Nat Med (2000) 4.69

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol (1997) 4.19

Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol (1999) 3.88

Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol (2000) 3.83

Infectious C-type virus isolated from a baboon placenta. Nature (1974) 3.32

Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol (1998) 3.16

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med (1999) 3.11

Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis (2000) 3.02

Evolution of type C viral genes: evidence for an Asian origin of man. Nature (1976) 3.02

A distinct class of inducible murine type-C viruses that replicates in the rabbit SIRC cell line. Proc Natl Acad Sci U S A (1974) 3.00

Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol (1995) 2.98

Homology between type-C viruses of various species as determined by molecular hybridization. Proc Natl Acad Sci U S A (1973) 2.90

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol (1999) 2.90

Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol (1997) 2.88

Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88

Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J Virol (1991) 2.84

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science (1992) 2.83

The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis (2001) 2.79

Evolution of C-type viral genes: inheritance of exogenously acquired viral genes. Nature (1974) 2.77

Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. J Virol (1986) 2.77

Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J Virol (1988) 2.76

Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science (1988) 2.76

Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci U S A (1975) 2.71

Detection of baboon type C viral sequences in various primate tissues by molecular hybridization. J Virol (1974) 2.69

Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62

Type C viruses of baboons: isolation from normal cell cultures. Cell (1974) 2.55

Nucleic acid homology of murine type-C viral genes. J Virol (1974) 2.51

Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol (1994) 2.45

Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus. J Virol (1985) 2.43

Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A (1995) 2.43

Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol (1998) 2.21

Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues. J Exp Med (1973) 2.13

Evolution of type C viral genes: origin of feline leukemia virus. Science (1975) 2.09

Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology (1995) 2.08

Evolution of type C viral genes: I. Nucleic acid from baboon type C virus as a measure of divergence among primate species. Proc Natl Acad Sci U S A (1974) 2.03

Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02

Multiple divergent copies of endogenous C-type virogenes in mammalian cells. Nature (1974) 1.99

Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol (1998) 1.98

Two distinct endogenous type C viruses isolated from the asian rodent Mus cervicolor: conservation of virogene sequences in related rodent species. J Virol (1977) 1.98

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. AIDS Res Hum Retroviruses (1998) 1.97

Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol (2000) 1.95

Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virus. J Virol (1978) 1.90

Characterization of exogenous type D retrovirus from a fibroma of a macaque with simian AIDS and fibromatosis. Science (1984) 1.89

Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS (2001) 1.88

Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis (1995) 1.86

Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1991) 1.83

Characterization of a type C virus released from the porcine cell line PK(15). Virology (1974) 1.81

Mammalian cells in culture frequently release type C viruses. Science (1973) 1.79

Enzymes that inactivate antibiotics in transit to their targets. Ann N Y Acad Sci (1974) 1.76

Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis (1998) 1.74

Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood (2000) 1.64

Interspecies antigenic determinants of the reverse transcriptases and p30 proteins of mammalian type C viruses. J Virol (1975) 1.64

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol (1995) 1.63

Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis (1995) 1.62

Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties. J Virol (1999) 1.61

Partial transcription of murine type C viral genomes in BALB c cell lines. J Virol (1973) 1.61

Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques. J Virol (1999) 1.60

Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus. J Acquir Immune Defic Syndr (1993) 1.58

Endogenous primate and feline type C viruses. Cold Spring Harb Symp Quant Biol (1975) 1.51

Identification of a cellular cofactor required for infection by feline leukemia virus. Science (2000) 1.49

Evolution of type C viral genes: preservation of ancestral murine type C viral sequences in pig cellular DNA. Proc Natl Acad Sci U S A (1975) 1.49

Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J Virol (2001) 1.48

Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A (1989) 1.47

A new class of genetically transmitted retravirus isolated from Mus cervicolor. Proc Natl Acad Sci U S A (1976) 1.46

A gene (Bevi) on human chromosome 6 is an integration site for baboon type C DNA provirus in human cells. Cell (1978) 1.45

A molecular solution to the riddle of the giant panda's phylogeny. Nature (1985) 1.43

Simian immunodeficiency virus is restricted to a subset of blood CD4+ lymphocytes that includes memory cells. J Immunol (1990) 1.43

Infectious primate type C viruses: Three isolates belonging to a new subgroup from the brains of normal gibbons. Virology (1975) 1.42

Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J Virol (1997) 1.41

MAC-1, a new genetically transmitted type C virus of primates: "low frequency" activation from stumptail monkey cell cultures. Cell (1978) 1.38

Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci U S A (1991) 1.37

Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. J Virol (1999) 1.37

Baboons and their close relatives are unusual among primates in their ability to release nondefective endogenous type C viruses. Virology (1976) 1.35

Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. J Med Primatol (1990) 1.35

T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS (1994) 1.32

Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine (1993) 1.32

Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J Virol (1996) 1.30

Phylogenetic evaluation of Kenyan HIV type 1 isolates. AIDS Res Hum Retroviruses (1997) 1.29

Biologic and immunologic properties of porcine type C viruses. Virology (1975) 1.28

An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis (1998) 1.26

Endogenous baboon type C virus (M7): biochemical and immunologic characterization. Virology (1974) 1.25

In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant. J Virol (1998) 1.23

Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus. Proc Natl Acad Sci U S A (1989) 1.21

Infectious type C viruses released by normal cat embryo cells. Virology (1973) 1.18

Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J Virol (2001) 1.18

Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J Virol (1994) 1.16

Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo. Virology (1999) 1.16

Replication and persistence of simian immunodeficiency virus variants after passage in macaque lymphocytes and established human cell lines. J Virol (1993) 1.15

Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants. J Virol (2001) 1.15

Type C viral expression in primate tissues. Proc Natl Acad Sci U S A (1974) 1.14

Isolation and characterization of a new type D retrovirus from the asian primate, Presbytis obscurus (spectacled langur). Virology (1978) 1.13

Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines. J Virol (1999) 1.11